DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,582,000 | -53.8% | 128,068 | -14.4% | 0.00% | -50.0% |
| Q2 2021 | $5,587,000 | +207.8% | 149,686 | +110.8% | 0.00% | +100.0% |
| Q1 2021 | $1,815,000 | +184.0% | 70,992 | +144.6% | 0.00% | – |
| Q4 2020 | $639,000 | -90.1% | 29,018 | -91.9% | 0.00% | -100.0% |
| Q3 2020 | $6,478,000 | +216.3% | 360,090 | +346.7% | 0.00% | +300.0% |
| Q2 2020 | $2,048,000 | +21.7% | 80,612 | -12.1% | 0.00% | -50.0% |
| Q1 2020 | $1,683,000 | +216.4% | 91,662 | +279.9% | 0.00% | +100.0% |
| Q4 2019 | $532,000 | +247.7% | 24,127 | +131.7% | 0.00% | – |
| Q1 2019 | $153,000 | +12.5% | 10,412 | -27.0% | 0.00% | – |
| Q1 2018 | $136,000 | +338.7% | 14,262 | +38.8% | 0.00% | – |
| Q2 2016 | $31,000 | – | 10,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $89,888,000 | 13.40% |
| EcoR1 Capital, LLC | 3,627,597 | $79,916,000 | 7.20% |
| Aquilo Capital Management, LLC | 614,436 | $13,536,000 | 5.08% |
| RTW INVESTMENTS, LP | 5,874,229 | $129,409,000 | 4.88% |
| BRIDGER MANAGEMENT, LLC | 1,981,633 | $43,655,000 | 3.15% |
| ACUTA CAPITAL PARTNERS, LLC | 387,500 | $8,537,000 | 2.11% |
| Integral Health Asset Management, LLC | 200,000 | $4,406,000 | 1.72% |
| Burrage Capital Management LLC | 104,047 | $2,292,000 | 1.54% |
| Parkman Healthcare Partners LLC | 240,000 | $5,287,000 | 1.53% |
| EAM Global Investors LLC | 122,237 | $2,693,000 | 1.08% |